FDA Approves Carl Zeiss Meditec's Cirrus HD-OCT for Dry AMD and Glaucoma
The FDA approved Carl Zeiss Meditec's Cirrus HD-OCT software version 6.0 for dry age-related macular degeneration and glaucoma, according to a company news release.
The system includes Advanced Retinal Pigment Epithelium Analysis, which enables physicians to monitor changes associated with dry AMD, and Enhanced Depth Imaging, which allows physicians to better visualize deep tissues.
Related Articles on Ophthalmology:
Dr. Paul Lee Appointed Director of the W.K. Kellogg Eye Center at University of Michigan
Florida Eye Institute to Offer New and Expanded Range of Lens Implants for Cataract Patients
Scientists Develop Contact Lenses That Provide a Continuous Supply of Anesthetic for Laser Eye Surgery Patients
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About